» Articles » PMID: 35864841

Head-to-tail Cyclization of Side Chain-protected Linear Peptides to Recapitulate Genetically-encoded Cyclized Peptides

Overview
Date 2022 Jul 22
PMID 35864841
Authors
Affiliations
Soon will be listed here.
Abstract

Genetically-encoded cyclic peptide libraries allow rapid screens for inhibitors of any target protein of interest. In particular, the Split Intein Circular Ligation of Protein and Peptides (SICLOPPS) system exploits spontaneous protein splicing of inteins to produce intracellular cyclic peptides. A previous SICLOPPS screen against Aurora B kinase, which plays a critical role during chromosome segregation, identified several candidate inhibitors that we sought to recapitulate by chemical synthesis. We describe the syntheses of cyclic peptide hits and analogs via solution-phase macrocyclization of side chain-protected linear peptides obtained from standard solid-phase peptide synthesis. Cyclic peptide targets, including cyclo-[CTWAR], were designed to match both the variable portions and conserved cysteine residue of their genetically-encoded counterparts. Synthetic products were characterized by tandem high-resolution mass spectrometry to analyze a combination of exact mass, isotopic pattern, and collisional dissociation-induced fragmentation pattern. The latter analyses facilitated the distinction between targets and oligomeric side products, and served to confirm peptidic sequences in a manner that can be readily extended to analyses of complex biological samples. This alternative chemical synthesis approach for cyclic peptides allows cost-effective validation and facile chemical elaboration of hit candidates from SICLOPPS screens.

Citing Articles

Peptide-Drug Conjugates: A New Hope for Cancer Management.

Chavda V, Solanki H, Davidson M, Apostolopoulos V, Bojarska J Molecules. 2022; 27(21).

PMID: 36364057 PMC: 9658517. DOI: 10.3390/molecules27217232.


Head-to-tail cyclization of side chain-protected linear peptides to recapitulate genetically-encoded cyclized peptides.

Bouayad-Gervais S, St-Cyr D, Courcelles M, Bonneil E, Gohard F, Thibault P Pept Sci (Hoboken). 2022; 114(3):e24254.

PMID: 35864841 PMC: 9286623. DOI: 10.1002/pep2.24254.

References
1.
Kritzer J, Hamamichi S, McCaffery J, Santagata S, Naumann T, Caldwell K . Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models. Nat Chem Biol. 2009; 5(9):655-63. PMC: 2729362. DOI: 10.1038/nchembio.193. View

2.
Gerry C, Schreiber S . Recent achievements and current trajectories of diversity-oriented synthesis. Curr Opin Chem Biol. 2019; 56:1-9. DOI: 10.1016/j.cbpa.2019.08.008. View

3.
Bouayad-Gervais S, St-Cyr D, Courcelles M, Bonneil E, Gohard F, Thibault P . Head-to-tail cyclization of side chain-protected linear peptides to recapitulate genetically-encoded cyclized peptides. Pept Sci (Hoboken). 2022; 114(3):e24254. PMC: 9286623. DOI: 10.1002/pep2.24254. View

4.
Gohard F, St-Cyr D, Tyers M, Earnshaw W . Targeting the INCENP IN-box-Aurora B interaction to inhibit CPC activity in vivo. Open Biol. 2014; 4(11):140163. PMC: 4248066. DOI: 10.1098/rsob.140163. View

5.
Trouche N, Wieckowski S, Sun W, Chaloin O, Hoebeke J, Fournel S . Small multivalent architectures mimicking homotrimers of the TNF superfamily member CD40L: delineating the relationship between structure and effector function. J Am Chem Soc. 2007; 129(44):13480-92. DOI: 10.1021/ja073169m. View